241 related articles for article (PubMed ID: 31118674)
1. NUT midline carcinoma of the head and neck: current perspectives.
Napolitano M; Venturelli M; Molinaro E; Toss A
Onco Targets Ther; 2019; 12():3235-3244. PubMed ID: 31118674
[No Abstract] [Full Text] [Related]
2. NUT Carcinoma: Clinicopathologic features, pathogenesis, and treatment.
French CA
Pathol Int; 2018 Nov; 68(11):583-595. PubMed ID: 30362654
[TBL] [Abstract][Full Text] [Related]
3. The importance of diagnosing NUT midline carcinoma.
French CA
Head Neck Pathol; 2013 Mar; 7(1):11-6. PubMed ID: 23463074
[TBL] [Abstract][Full Text] [Related]
4. NUT midline carcinoma of the larynx: an international series and review of the literature.
Hellquist H; French CA; Bishop JA; Coca-Pelaz A; Propst EJ; Paiva Correia A; Ngan BY; Grant R; Cipriani NA; Vokes D; Henrique R; Pardal F; Vizcaino JR; Rinaldo A; Ferlito A
Histopathology; 2017 May; 70(6):861-868. PubMed ID: 27926786
[TBL] [Abstract][Full Text] [Related]
5. Combined Targeting of the BRD4-NUT-p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734.
Morrison-Smith CD; Knox TM; Filic I; Soroko KM; Eschle BK; Wilkens MK; Gokhale PC; Giles F; Griffin A; Brown B; Shapiro GI; Zucconi BE; Cole PA; Lemieux ME; French CA
Mol Cancer Ther; 2020 Jul; 19(7):1406-1414. PubMed ID: 32371576
[TBL] [Abstract][Full Text] [Related]
6. HDAC Overexpression in a NUT Midline Carcinoma of the Parotid Gland with Exceptional Survival: A Case Report.
Esteves G; Ferreira J; Afonso R; Martins C; Zagalo C; Félix A
Head Neck Pathol; 2020 Dec; 14(4):1117-1122. PubMed ID: 31989434
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of NUT midline carcinoma.
French CA
Annu Rev Pathol; 2012; 7():247-65. PubMed ID: 22017582
[TBL] [Abstract][Full Text] [Related]
8. Cytopathologic features of NUT midline carcinoma: A series of 26 specimens from 13 patients.
Bishop JA; French CA; Ali SZ
Cancer Cytopathol; 2016 Dec; 124(12):901-908. PubMed ID: 27400194
[TBL] [Abstract][Full Text] [Related]
9. NUT midline carcinoma: Current concepts and future perspectives of a novel tumour entity.
Salati M; Baldessari C; Bonetti LR; Messina C; Merz V; Cerbelli B; Botticelli A
Crit Rev Oncol Hematol; 2019 Dec; 144():102826. PubMed ID: 31707223
[TBL] [Abstract][Full Text] [Related]
10. Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck.
Chau NG; Hurwitz S; Mitchell CM; Aserlind A; Grunfeld N; Kaplan L; Hsi P; Bauer DE; Lathan CS; Rodriguez-Galindo C; Tishler RB; Haddad RI; Sallan SE; Bradner JE; French CA
Cancer; 2016 Dec; 122(23):3632-3640. PubMed ID: 27509377
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma.
Zhang X; Zegar T; Lucas A; Morrison-Smith C; Knox T; French CA; Knapp S; Müller S; Siveke JT
Oncogene; 2020 Jun; 39(24):4770-4779. PubMed ID: 32366905
[TBL] [Abstract][Full Text] [Related]
12. Small-Molecule Targeting of BET Proteins in Cancer.
French CA
Adv Cancer Res; 2016; 131():21-58. PubMed ID: 27451123
[TBL] [Abstract][Full Text] [Related]
13. NUT midline carcinoma.
French CA
Cancer Genet Cytogenet; 2010 Nov; 203(1):16-20. PubMed ID: 20951314
[TBL] [Abstract][Full Text] [Related]
14. Primary pulmonary NUT midline carcinoma: An elusive and a rare diagnostic entity.
Pasricha S; Jajodia A; Sharma A; Bansal D; Batra U; Gupta G; Durga G; Kamboj M; Nathany S; Mehta A
J Cancer Res Ther; 2023; 19(3):816-818. PubMed ID: 37470617
[TBL] [Abstract][Full Text] [Related]
15. Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma.
Lee JK; Louzada S; An Y; Kim SY; Kim S; Youk J; Park S; Koo SH; Keam B; Jeon YK; Ku JL; Yang F; Kim TM; Ju YS
Ann Oncol; 2017 Apr; 28(4):890-897. PubMed ID: 28203693
[TBL] [Abstract][Full Text] [Related]
16. Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma.
Thompson-Wicking K; Francis RW; Stirnweiss A; Ferrari E; Welch MD; Baker E; Murch AR; Gout AM; Carter KW; Charles AK; Phillips MB; Kees UR; Beesley AH
Oncogene; 2013 Sep; 32(39):4664-74. PubMed ID: 23128391
[TBL] [Abstract][Full Text] [Related]
17. NUT Midline Carcinoma: A Series of Five Cases, Including One with Unusual Clinical Course.
Kakkar A; Antony VM; Irugu DVK; Adhikari N; Jain D
Head Neck Pathol; 2018 Jun; 12(2):230-236. PubMed ID: 28948459
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitor for NUT midline carcinoma.
Maher OM; Christensen AM; Yedururi S; Bell D; Tarek N
Pediatr Blood Cancer; 2015 Apr; 62(4):715-7. PubMed ID: 25557064
[TBL] [Abstract][Full Text] [Related]
19. Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628.
Stathis A; Zucca E; Bekradda M; Gomez-Roca C; Delord JP; de La Motte Rouge T; Uro-Coste E; de Braud F; Pelosi G; French CA
Cancer Discov; 2016 May; 6(5):492-500. PubMed ID: 26976114
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
